Holen Sie sich die Stockscreener-App
322.61
5.64%
17.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$305.35
Offen:
$314.765
24-Stunden-Volumen:
5.75M
Relative Volume:
0.59
Marktkapitalisierung:
$403.41B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
60.89
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+17.99%
1M Leistung:
+20.46%
6M Leistung:
+107.92%
1J Leistung:
+297.93%
1-Tages-Spanne:
$309.65
$322.80
1-Wochen-Bereich:
$277.52
$322.60
52-Wochen-Spanne:
$79.49
$322.60
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
322.58 | 381.86B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,632.91 | 629.35B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
453.87 | 343.12B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
2,009.94 | 246.67B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
386.98 | 56.11B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp Stock (LRCX) Moved Up by 3.23% on May 26: What Signal Does It Send? - TradingKey
Lam Research Corporation (LRCX) Rallied on AI-Driven Strong Demand - Yahoo Finance
Lam Research Corp (NASDAQ:LRCX) Meets Minervini Trend Template and High Growth Momentum Criteria - ChartMill
Lam Research Corporation stock (US5324571083): chip-equipment demand and AI boom keep focus on earni - AD HOC NEWS
Lam Research Corporation $LRCX Shares Sold by LSV Asset Management - MarketBeat
Atlatl Advisers LLC Has $3.02 Million Position in Lam Research Corporation $LRCX - MarketBeat
Allstate Corp Buys 49,743 Shares of Lam Research Corporation $LRCX - MarketBeat
Is Wall Street bullish or bearish on Lam Research stock? - MSN
Wealthquest Corp Takes Position in Lam Research Corporation $LRCX - MarketBeat
Legal & General Group Plc Lowers Holdings in Lam Research Corporation $LRCX - MarketBeat
Prospera Financial Services Inc Sells 17,548 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research’s SWOT analysis: stock faces cleanroom constraints - Investing.com
Lam Research (LRCX) Upgraded by Morgan Stanley with New Price Ta - GuruFocus
Steward Large Cap Core Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Is Lam Research Corporation (LRCX) One of the Best Oversold Growth Stocks to Invest in Now? - Insider Monkey
GPS Wealth Strategies Group LLC Sells 15,216 Shares of Lam Research Corporation $LRCX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Axxcess Wealth Management LLC Boosts Stake in Lam Research Corporation $LRCX - MarketBeat
Associated Banc Corp Trims Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Expands AI Integration and Investment in Sem - GuruFocus
Lam Research (LRCX) Declares Quarterly Dividend of $0.26 - GuruFocus
Lam Research Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Wall Street Bullish or Bearish on Lam Research Stock? - Barchart.com
LVIP Nomura U.S. Growth Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Why Is Lam Research (LRCX) Up 16.9% Since Last Earnings Report? - Yahoo Finance
Lam Research Corporation $LRCX Shares Acquired by Keystone Financial Group - MarketBeat
Lam Research Corp at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
LRCX News | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Fidelity Trend Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research CEO: Focusing on AI integration in chipmaking tools, plans to expand U.S. operations - 富途牛牛
Lam Research Corp (LRCX) Shares Surge 3.5% -- What GF Score of 8 - GuruFocus
Lam Research Rally Puts Nasdaq Futures In Focus - Kalkine Media
Lam Research declares $0.26 quarterly dividend - Investing.com
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research Keeps Quarterly Dividend at $0.26 per Share, Payable on July 8 to Holders on Record as of June 17 - Moomoo
Lam Research Corporation Declares Quarterly Dividend - PR Newswire
Lam Research Corp Stock (LRCX) Moved Up by 3.46% on May 21: Drivers Behind the Movement - TradingKey
Lam Research (NASDAQ:LRCX) Hits New 12-Month High After Analyst Upgrade - MarketBeat
Lam Research Corp stock hits all-time high at 302.04 USD - Investing.com Nigeria
Chip Demand Momentum Lifts Lam Research In Nasdaq Composite - Kalkine Media
Lam Research (LRCX) Just Overtook the 20-Day Moving Average - Yahoo Finance
Lam Research Corp stock (US5184391044): shares jump after 6.8% move – what’s driving the momentu - AD HOC NEWS
Goldenstone Wealth Management LLC Purchases New Shares in Lam Research Corporation $LRCX - MarketBeat
LAM RESEARCH CORP (NASDAQ:LRCX) Fits the GARP Mold with Strong Growth and Reasonable Valuation - ChartMill
IBM and Lam Research team up to advance sub-1nm chip technology - MSN
ABN Amro Investment Solutions Buys 84,170 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research opens Austria lab to advance chip packaging, cut costs - ET Telecom
Lam Research Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MSN
A Look at Lam Research Corp (LRCX) After 6.8% Gain -- GF Value $127.08 vs Price $292.09 - GuruFocus
LRCX Overweight: How Lam Research Is Poised to Outperform the $149B WFE Market - Barchart.com
S&P 500 Rebounds Ahead Of Nvidia's Print, Oil Sinks 5% On Iran Truce Hopes: Stock Market Today - Benzinga
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Fernandes Neil J | Senior Vice President |
May 01 '26 |
Sale |
255.14 |
18,170 |
4,635,894 |
66,129 |
4.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):